BIO-CHEM(SH:603360)2024-08-28 08:58Financial Performance - The company's operating revenue for the first half of 2024 was ¥582,918,534.52, representing a 1.72% increase compared to ¥573,035,795.24 in the same period last year[12]. - The net profit attributable to shareholders for the first half of 2024 was ¥164,551,418.82, a decrease of 13.33% from ¥189,858,191.21 in the previous year[12]. - The net cash flow from operating activities decreased significantly by 75.66%, amounting to ¥57,497,953.13 compared to ¥236,199,081.60 in the same period last year[12]. - Basic earnings per share for the first half of 2024 were ¥0.33, down 13.16% from ¥0.38 in the same period last year[13]. - The weighted average return on net assets was 9.78%, a decrease of 2.42 percentage points from 12.20% in the previous year[13]. - The net profit after deducting non-recurring gains and losses was ¥157,064,854.79, down 16.80% from ¥188,776,204.76 in the same period last year[12]. - The company reported a decrease in diluted earnings per share to ¥0.33, down from ¥0.38 in the previous year[13]. - The company achieved operating revenue of 582.92 million yuan in the first half of 2024, a year-on-year increase of 1.72%[19]. - The net profit attributable to shareholders was 164.55 million yuan, a decrease of 13.33% compared to the same period last year[19]. - The company reported a total profit of ¥186,801,222.70 for the first half of 2024, down from ¥219,985,552.28 in the previous year, a decrease of about 15.1%[65]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,935,322,804.69, a slight decrease of 0.33% from ¥1,941,704,269.90 at the end of the previous year[12]. - The net assets attributable to shareholders decreased by 2.25%, totaling ¥1,599,881,169.00 compared to ¥1,636,719,076.66 at the end of the previous year[12]. - Total assets at the end of the reporting period were 1,935.32 million yuan, with equity attributable to the parent company decreasing by 0.33% to 1,599.88 million yuan[20]. - The total liabilities rose to ¥335,816,635.69 from ¥304,985,193.24, an increase of about 10.1%[63]. - Owner's equity totaled CNY 1,599,881,169.00, down from CNY 1,636,719,076.66, reflecting a decrease of approximately 2.3%[60]. - The company reported a total liability of CNY 335,441,635.69, an increase from CNY 304,985,193.24, reflecting a growth of approximately 9.4%[60]. Production and Operations - The company's main business is the research, production, and sales of isothiazolinone industrial biocide raw materials, which account for 98.50% of total revenue, providing stable cash flow[17]. - The company has over 40,000 tons/year of production capacity for isothiazolinone industrial biocides, making it the largest producer in Asia[16]. - The production volume of isothiazolinone industrial biocides reached 17,929.99 tons, while sales volume was 22,060.48 tons, representing increases of 4.00% and 33.57% respectively[19]. - The company has established stable long-term partnerships with key clients such as Lanxess, Osha, and Troy, ensuring reliable product quality and supply[16]. - The company’s core products include CIT/MIT, MIT, OIT, DCOIT, and BIT series, widely used in various industries such as oilfield water injection and coatings[16]. Research and Development - Research and development expenses increased by 18.27% to 21.36 million yuan, reflecting the company's commitment to innovation[20]. - The company has established a high-standard R&D team and has been recognized as a high-tech enterprise since October 2011[18]. Environmental Compliance - The company maintains a strong focus on safety and environmental protection, ensuring compliance with national standards and investing in employee training[18]. - The company’s wastewater discharge for chemical oxygen demand (COD) is 17.402 tons, with ammonia nitrogen at 0.652 tons, both meeting standards[38]. - The company passed the environmental management system re-evaluation in April 2024 and completed the annual certification[44]. - There were no administrative penalties due to environmental issues during the reporting period[46]. Shareholder and Capital Structure - The company implemented a stock dividend of 0.4 shares per share, increasing the total share capital from 360,318,191 shares to 504,445,467 shares[14]. - The total share capital increased to 504,445,467 shares after a bonus issue of 144,127,276 shares, representing a 39.91% increase[51]. - The company completed the distribution of 0.4 bonus shares per share to all shareholders on May 31, 2024[51]. - The total number of shareholders reached 11,528 by the end of the reporting period[54]. - The top shareholder, Dalian Tongyun Investment Co., Ltd., holds 151,129,657 shares, accounting for 29.96% of the total shares[54]. Cash Flow and Financing Activities - Cash inflow from financing activities reached ¥273,917,998.90, up from ¥50,000,000.00 in the same period last year[72]. - The net cash flow from financing activities was -¥99,811,281.85, an improvement from -¥205,956,398.60 in the previous year[72]. - The company received ¥205,000,000.00 in borrowings during the first half of 2024, a significant increase from ¥50,000,000.00 in the same period of 2023[72]. Risk Management - The company highlighted the risk of raw material price fluctuations, which could impact operational efficiency, and plans to enhance supplier management and market analysis[26]. - The company faced environmental protection risks due to its operations in a heavily regulated industry, necessitating increased investment in environmental protection measures[26]. Stock Incentive Plans - The company has an ongoing stock incentive plan, granting a total of 5.82 million restricted stocks to 64 individuals, with an initial grant price of 7.36 yuan per share[33]. - The company completed the registration of the first grant of the restricted stock incentive plan on June 17, 2021[4]. - The company adjusted the performance assessment indicators of the 2021 restricted stock incentive plan due to changes in the external operating environment[35]. Financial Reporting and Compliance - The company’s financial statements comply with accounting standards, reflecting its financial position and operational results accurately[87]. - The company has implemented a new accounting policy effective January 1, 2024, with no significant impact on financial statements[150]. - The company recognizes revenue when control of goods or services is transferred to the customer, either at a point in time or over time based on performance obligations[133].